EBI3 and diffuse large B-cell lymphoma: Significantly increased expression of p35 mRNA was found in DLBCL patients compared to the healthy controls (61.49 ± 13.58 vs. 20.34 ± 7.06; p < 0.01, Figure 4A), as well as expression of EBI3 mRNA (21.88 ± 6.06 vs. 4.76 ± 2.43; p < 0.01, Figure 4B).